Regulation of target gene expression by the vitamin D receptor - An update on mechanisms

Reviews in Endocrine and Metabolic Disorders

Volumn 13, Issue 1, 2012, Pages 45-55

  Pike, J Wesley ^a   Meyer, Mark B ^a   Bishop, Kathleen A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Acetylation; ChIP chip; ChIP seq; CYP24A1; Enhancers; RXR; Tnfsf11 Rankl; Transcription; VDR

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; MOLECULAR MECHANICS; NONHUMAN; OSTEOBLAST; PROTEIN BINDING; REVIEW;

ACETYLATION; ANIMALS; GENE EXPRESSION; HUMANS; MICE; MODELS, BIOLOGICAL; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES;

EID: 84858154398     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9198-9     Document Type: Review

References (81)

1. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S-96.
2. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941-55.
3. 3. J Steroid Biochem Mol Biol. 2010;121:130-5.
4. Hoenderop JGJ, Nilius B, Bindels RJM. Calcium absorption across epithelia. Physiol Rev. 2005;85:373-422. (Pubitemid 40171261)
5. 2+ entry at the gate. Pflugers Arch. 2005;451:181-92.
6. Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009;297:F282-91.
7. Segawa H, Onitsuka A, Furutani J, Kaneko I, Aranami F, Matsumoto N, et al. Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am J Physiol Renal Physiol. 2009;297:F671-8.
8. Tomoe Y, Segawa H, Shiozawa K, Kaneko I, Tominaga R, Hanabusa E, et al. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice. Am J Physiol Renal Physiol. 2010;298: F1341-50.
9. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165-76. (Pubitemid 28180851)
10. Bucay N, Sarosi I, Dunstan C, Morony S, Tarpley J, Capparelli C, et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-8. (Pubitemid 28213402)
11. Bergwitz C, Banerjee S, Abu-Zahra H, Kaji H, Miyauchi A, Sugimoto T, et al. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab. 2009;94:4267-74.
12. Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61:91-104.
13. Abe E,Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, et al. Differentiation of mouse myeloid leukemia cells induced by 1a,25- dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981;78:4990-4. (Pubitemid 12225607)
14. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296:1313-6. (Pubitemid 34522785)
15. 3 is human cell line-specific and is unlikely to involve pregnane X receptor. Drug Metab Dispos. 2001;29:1446-53.
16. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, et al. Transcriptional control of intestinal cytochrome P-4503A by 1a,25-dihydroxy vitamin D3. Mol Pharmacol. 2001;60:1399-406. (Pubitemid 33144911)
17. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011;86:23-62.
18. Bikle DD. Vitamin D and the skin. J Bone Miner Metab. 2010;28:117-30.
19. Cianferotti L, Cox M, Skorija K, Demay MB. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci U S A. 2007;104:9428-33. (Pubitemid 47185796)
20. Wu-Wong JR. The potential for vitamin D receptor activation in cardiovascular research. Exp Opin Invest Drugs. 2007;16:407-11. (Pubitemid 46554459)
21. Wu-Wong JR. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol. 2009;158:395-412.
22. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988;85:3294-8.
23. 3 receptor cDNA. Proc Natl Acad Sci U S A. 1988;85:1005-9.
24. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-95.
25. Haussler M, Whitfield G, Haussler C, Hsieh J, Thompson P, Selznick S, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325-49. (Pubitemid 28146215)
26. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell. 2000;5:173-9. (Pubitemid 30105446)
27. 3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry. 2004;43:4101-10.
28. Pike J, Sleator N. Hormone-dependent phosphorylation of the 1,25-dihydroxyvitamin D3 receptor in mouse fibroblasts. Biochem Biophys Res Commun. 1985;131:378-85. (Pubitemid 16251158)
29. Hsieh JC, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu Y, et al. Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem. 1993;268:15118-26. (Pubitemid 23206664)
30. Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A. 1989;86:4455-9. (Pubitemid 19164573)
31. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem. 1990;265:21881-8. (Pubitemid 120014238)
32. Carlberg C. Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem. 2003;88:274-81. (Pubitemid 36119898)
33. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841-50. (Pubitemid 26006526)
34. 3. Proc Natl Acad Sci U S A. 1992;89:8097-101.
35. 3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol. 2007; 21:334-42.
36. Murayama A, Kim MS, Yanagisawa J, Takeyama K, Kato S. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2004;23:1598-608. (Pubitemid 38579520)
37. 3- induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol. 2007;265-266:168-73.
38. McKenna N, O'Malley B. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002;108:465-74. (Pubitemid 34260872)
39. Ren B. Transcription: Enhancers make non-coding RNA. Nature. 2010;465:173-4.
40. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. In: Nat Rev Genet. 2010;476-486
41. Pike JW. Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation. J Bone Miner Res. 2011;26:1155-62.
42. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res. 2007;22 Suppl 2:V2-10.
43. Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem. 2010;21:1153-61.
44. Nehring J, Zierold C, DeLuca H. Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci U S A. 2007;104:10006-9. (Pubitemid 47175253)
45. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, Mangelsdorf DJ. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem. 2010;285:14486-94.
46. Marx SJ, Spiegel AM, Brown EM, Gardner DG, Downs RW, Attie M, et al. A familial syndrome of decrease in sensitivity to 1,25- dihydroxyvitamin D. J Clin Endocrinol Metab. 1978;47:1303-10. (Pubitemid 9091293)
47. Malloy P, Xu R, Cattani A, Reyes L, Feldman D. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res. 2004;19:1018-24. (Pubitemid 41103460)
48. Balsan S, Garabédian M, Larchet M, Gorski AM, Cournot G, Tau C, et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest. 1986;77:1661-7. (Pubitemid 16047112)
49. Eil C, Liberman UA, Rosen JF, Marx SJ. A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N Engl J Med. 1981;304:1588-91. (Pubitemid 11122509)
50. 3 in humans are transcriptionally inactive in vitro. J Biol Chem. 1989;264:20230-4.
51. Forghani N, Lum C, Krishnan S, Wang J, Wilson D, Blackett P, et al. Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene. J Pediatr Endocrinol Metab. 2010;23:843-50.
52. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol. 2005;19:855-62. (Pubitemid 40397051)
53. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-76.
54. Kirmizis A, Farnham PJ. Genomic approaches that aid in the identification of transcription factor target genes. Exp Biol Med (Maywood). 2004;229:705-21. (Pubitemid 39166475)
55. Valouev A, Johnson D, Sundquist A, Medina C, Anton E, Batzoglou S, et al. Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat Methods. 2008;5:829-34.
56. McDowell JC, Park M, Thomas PJ, Young AC, Blakesley RW, Muzny DM, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799-816.
57. Meyer MB, Goetsch PD, Pike JW. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Biol. 2010;121:136-41.
58. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352-60.
59. 3 is mediated through multiple long-range enhancers. Mol Cell Biol. 2006;26:6469-86.
60. Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol. 2006;20:1231-47. (Pubitemid 43801228)
61. 3. J Biol Chem. 2010;285:15599-610.
62. Jin CH, Pike JW. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol Endocrinol. 1996;10:196-205. (Pubitemid 26042551)
63. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell. 2005;122:33-43. (Pubitemid 40977938)
64. Carroll J, Meyer C, Song J, Li W, Geistlinger T, Eeckhoute J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289-97. (Pubitemid 44646291)
65. Zella L, Meyer M, Nerenz R, Lee S, Martowicz M, Pike J. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol. 2010;24:128-47.
66. Martowicz ML, Meyer MB, Pike JW. The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers. J. Cell. Biochem. 2011;112:2030-45.
67. Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011;12:283-93.
68. 3 on genes involved in calcium homeostasis. J Bone Miner Res. 2007;22 Suppl 2:V16-9.
69. Yasuda H, Higashio K, Suda T. Vitamin D and osteoclastogenesis. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. 2nd ed. New York: Elsevier/Academic Press; 2005. p. 665-85.
70. Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci. 2008;1143:123-50.
71. 3supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem. 2003;89:771-7.
72. Fan X, Roy E, Murphy T, Nanes M, Kim S, Pike J, et al. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J Cell Biochem. 2004;93:807-18. (Pubitemid 44264175)
73. Nerenz RD, Martowicz ML, Pike JW. An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. Mol Endocrinol. 2008;22:1044-56. (Pubitemid 351629606)
74. Fu Q, Manolagas SC, O'Brien CA. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol. 2006;26:6453-68. (Pubitemid 44277886)
75. Kim S, Yamazaki M, ShevdeNK, Pike JW. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol. 2007;21:197-214. (Pubitemid 46041700)
76. Bishop KA, Meyer MB, Pike JW. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol Endocrinol. 2009;23:2095-110.
77. Bishop KA, Coy HM, Nerenz RD, Meyer MB, Pike JW. Mouse Rankl expression is regulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control region. J. Biol. Chem. 2011;286:20880-91.
78. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science. 2002;295:1306-11. (Pubitemid 34157624)
79. Tasic B, Hippenmeyer S, Wang C, Gamboa M, Zong H, Chen-Tsai Y, et al. Site-specific integrase-mediated transgenesis in mice via pronuclear injection. Proc Natl Acad Sci U S A. 2011;108:7902-7.
80. Galli C, Zella LA, Fretz JA, Fu Q, Pike JW, Weinstein RS, et al. Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology. 2008;149:146-53.
81. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol. 2010;11:635-43.